Citius Oncology, Inc. ( CTOR) - Key Metrics
CTOR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0.01 | -$0.08 | -$0.03 | -$0.03 |
| 2026Q2 | $0.02 | -$0.27 | -$0.04 | -$0.04 |
| 2026Q1 | $0.05 | -$0.06 | -$0.08 | -$0.08 |
| 2025Q4 | $0 | -$0.06 | -$0.07 | -$0.07 |
| 2025Q3 | $0 | -$0.08 | $0 | $0 |
CTOR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -1.97 |
| 2026Q2 | 0% | -0.57 |
| 2026Q1 | 0% | -3.95 |
| 2025Q4 | 0% | -8.23 |
| 2025Q3 | 0% | -14.50 |
CTOR
Price: $0.92
52 week price:
Earnings Per Share: -0.48 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 80.0 million